Don't have an account?
Echocardiography is a prime example of how artificial intelligence (AI) is reshaping healthcare. Earlier this year GE HealthCare announced the availability of Caption AITM & Caption GuidanceTM on its Vscan AirTM SL handheld ultrasound device, in addition to the VenueTM Point of Care Family. This AI integration provides bedside echo users with real-time, step-by-step scan guidance, including prompts on probe movements, to ensure they capture diagnostic-quality images. Caption AI also automatically calculates left ventricular ejection fraction (LVEF), a crucial measure in diagnosing and assessing various cardiac conditions, particularly heart failure.
The implications of AI assistance in rapid point-of-care cardiac assessments are profound. It empowers more clinicians of all experience levels to confidently capture diagnostic quality images so they can make timely, well-informed treatment decisions. The advantages of AI in focused echocardiography also reverberate within echo lab operations, where it creates potential for new levels of efficiency
Echo labs are under strain. Globally, the annual tally of echocardiography exams stands at 108 million1 and it is expected to remain a mainstay of patient care. This demand for resources is compounded by workforce challenges. The U.S. Bureau of Labor Statistics forecast an overallsonographer shortfall as experienced technologists are leaving the workforce for varying reasons. The demand for cardiac sonographers is particularly high due to the specialized nature of their work and the growing need for cardiovascular diagnostics3. The aging population significantly contributes to this demand, as older adults are more likely to require cardiovascular care.
For many echo labs these factors translate into a significant backlog of echocardiogram appointments, which in turn prolong patient wait time. Echo labs must find ways to optimize resource utilization and provide timely access to diagnostics for patients amid escalating echo exams volume.
Providers across a range of clinical areas including primary care, internal medicine, emergency and critical care, women’s health, and pulmonary medicine are beginning to integrate handheld ultrasound devices into their standard toolkits. Evidence already shows that their use can lead to faster, safer, more accurate, and more affordable patient care3.
The widespread availability of handheld ultrasound devices represents a significant shift in cardiac care. Echocardiography is crucial for assessing cardiac structure and function, aiding in diagnosing and managing cardiovascular conditions. Traditionally conducted in specialized echo labs, point-of-care ultrasound now allows for focused bedside, ambulance, or home-based cardiac assessments, decentralizing access to these exams.
Though a potentially powerful diagnostic aid, the experience level of the clinician conducting a rapid cardiac assessment at the point of care impacts clinical next steps. Newer users may obtain images with limited visibility of cardiac structures or artifacts. There is also the potential for false positives which can unnecessarily consume cardiology resources. The prevalence of unneeded echo lab referrals is already a general utilization concern being looked at globally—a recent study found that, among patients without known cardiovascular disease who were referred for an echo due to chest pain, dyspnea, or palpitations, between 62-87% of cases did not have abnormal cardiac findings4.
Adoption of AI-driven scan guidance could significantly reduce the learning curve for ultrasound usage, and as a result, optimize the cardiac care pathway. This can trigger a number of operational benefits in the echo lab.
Above all, the adoption of AI guidance in focused cardiac assessments has exciting potential for improving patient experience. Patients can benefit from prompt initiation of appropriate interventions or reassurance if no significant abnormalities are detected.
JB29599XX